Phase II study of metronomic chemotherapy (MC) with bevacizumab (B) in patients (Pts) with advanced (Adv) nonsquamous non-small cell lung cancer (NS-NSCLC).
Carrie Lee Marquette
No relevant relationships to disclose
Stefan C. Grant
No relevant relationships to disclose
Mollie DeShazo
No relevant relationships to disclose
Vishnu Reddy
No relevant relationships to disclose
Alan Cantor
No relevant relationships to disclose
Debi Miley
No relevant relationships to disclose
Mary Jerome
No relevant relationships to disclose
Francisco Robert
Research Funding - University of Alabama